| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 12 |
| 1 | ASPIRIN | 10 |
| 2 | ASPIRIN 325 MG | 9 |
| 3 | ASPIRIN 81 MG | 9 |
| 4 | PREDNISONE | 6 |
| 5 | CLOPIDOGREL | 5 |
| 6 | METHYLPREDNISOLONE SODIUM SUCCINATE | 5 |
| 7 | AMLODIPINE | 4 |
| 8 | BEVACIZUMAB | 4 |
| 9 | CLOPIDOGREL BISULFATE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM FERRIC GLUCONATE COMPLEX | 3 | 0.0014 |
| 1 | TRIPTORELIN | 3 | 0.0009 |
| 2 | TRANDOLAPRIL TABLETS | 1 | 0.0005 |
| 3 | INSULIN GLULISINE | 3 | 0.0003 |
| 4 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 5 | APALUTAMIDE | 3 | 0.0002 |
| 6 | TRAZODONE HYDROCHLORIDE | 3 | 0.0002 |
| 7 | CEFEPIME HYDROCHLORIDE | 3 | 0.0002 |
| 8 | SOFOSBUVIR | 3 | 0.0002 |
| 9 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Parenteral Iron Replacement [EPC] | 3 | 0.0002 |
| 1 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |
| 2 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 3 | Factor Xa Inhibitor [EPC] | 14 | 0.0001 |
| 4 | Nucleoside Analog Antiviral [EPC] | 4 | 0.0000 |
| 5 | Epidermal Growth Factor Receptor Antagonist [EPC] | 2 | 0.0000 |
| 6 | CTLA-4-directed Blocking Antibody [EPC] | 2 | 0.0000 |
| 7 | P2Y12 Platelet Inhibitor [EPC] | 4 | 0.0000 |
| 8 | Cytochrome P450 3A Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 | 0.0000 |